Sio Gene Therapies Inc.

OTCPK:SIOX Stock Report

Market Cap: US$34.8m

Sio Gene Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SIOX?
Owner TypeNumber of SharesOwnership Percentage
Institutions6250.000845%
Individual Insiders88,3530.119%
Public Companies18,577,38025.1%
General Public55,308,83874.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 5 shareholders own 25.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
25.1%
Roivant Sciences Ltd.
18,577,380US$8.7m0%no data
0.061%
David Nassif
45,244US$21.3k0%no data
0.045%
Atul Pande
33,370US$15.7k0%no data
0.013%
Berndt Axel Modig
9,739US$4.6k0%no data
0.00084%
LLB Invest Kapitalanlagegesellschaft m.b.H.
625US$292.10%no data